New Brunswick, NJ, June 3, 2013 ― The HealthCare Institute of New Jersey (HINJ) has released the following statement on the passing this morning of U.S. Senator Frank R. Lautenberg.
* * *
“Senator Lautenberg was one of our nation’s strongest champions of patients, spending his long legislative career protecting their access to the treatments, medicines, devices and technologies they need. His tenacious advocacy on behalf of patients has doubtless improved untold numbers of lives — in New Jersey and around the globe — who will remain indebted to him for his tireless work. HINJ mourns his passing.”
Founded in 1997, the HealthCare Institute of New Jersey (HINJ) serves as the voice for the state’s life sciences industry. HINJ seeks to expand patient access to the most innovative biopharmaceuticals and medical devices and promote awareness of the industry’s impact on New Jersey’s quality of life and economic well-being. In 2010, HINJ member companies’ economic impact in the state exceeded $24 billion, according to HINJ’s 2011 Economic Impact Report. To learn more, please visit HINJ at www.hinj.org or follow us via Twitter @ HINJ_ORG, Facebook @ HealthCareInstituteofNewJersey or YouTube @HINJNJ.